title: Targeting the JAK2-STAT5 pathway in CML.
authors.affiliation: MEDICAL UNIVERSITY OF VIENNA.
authors.forename: Peter
authors.initials: P
authors.lastname: Valent
mesh_terms: D000818:Animals; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D009570:Nitriles; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011720:Pyrazoles / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D050799:STAT5 Transcription Factor / Q000037:antagonists & inhibitors*
chemical_list: D009570:Nitriles; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; D050799:STAT5 Transcription Factor; C540383:ruxolitinib; C507924:JAK2 protein, human; D053614:Janus Kinase 2; C498826:nilotinib